Concepedia

Ayumi Sakai

AS

7

Publications

265

Citations

7

H-Index

2013

Active since

Affiliations

Osaka City University(Current)

University of Toyama

Japan Science and Technology Agency

Ayumi Sakai is an author at Osaka City University specializing in alzheimer's disease, health sciences, and drug discovery.

Top concepts

Publications per year

2013–2024

7

Publications

7

Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers

Tomohiro Umeda, Kenjiro Ono, Ayumi Sakai et al. · Brain · 2016 · 118 citations · Full text

Intranasal rifampicin for Alzheimer's disease prevention

Tomohiro Umeda, Akiko Tanaka, Ayumi Sakai et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2018 · 38 citations · Full text

Oligomer-Targeting Prevention of Neurodegenerative Dementia by Intranasal Rifampicin and Resveratrol Combination – A Preclinical Study in Model Mice

Tomohiro Umeda, Ayumi Sakai, Keiko Shigemori et al. · Frontiers in Neuroscience · 2021 · 33 citations · Full text

, , +21

Mutation-induced loss of APP function causes GABAergic depletion in recessive familial Alzheimer’s disease: analysis of Osaka mutation-knockin mice

Tomohiro Umeda, Tetsuya Kimura, Kayo Yoshida et al. · Acta Neuropathologica Communications · 2017 · 27 citations · Full text

Nasal Rifampicin Improves Cognition in a Mouse Model of Dementia with Lewy Bodies by Reducing α-Synuclein Oligomers

Tomohiro Umeda, Yukari Hatanaka, Ayumi Sakai et al. · International Journal of Molecular Sciences · 2021 · 21 citations · Full text

Rows per page

1–5 of 7